Subscribe to Search results

The Haemophilia Society asked to be assured that there would be no ban on importing foreign blood products.

Published on:

A Haemophilia Society Press Release stated that they were not planning to seek compensation from the Government and their priority was to ensure help and support for those with Hepatitis C.

Published on:

Dr Jones provided an update on Hepatitis in the Haemophilia Society Newsletter. He stated that there was "no increase in the death rate from liver failure" and that whilst risks remained, they were "probably of less consequence than might be suggested by the literature".

Published on:

Dr Jones made a statement following the World in Action documentary. Dr Jones set out "the facts", including an explanation of the "theoretical risk of virus transmission" increasing from 3 to 1 in fresh frozen plasma to between 500 to 1 and 3000 to 1 for AHG concentrate, and to state that "Of course the actual risk will be much lower than these figures suggest as only a very small proportion of donors may carry the virus".

Published on:

Haemophilia Society committee members attended the First International Conference on Haemophilia held in Bonn, Germany.

Published on:

The Haemophilia Society wrote to Professor Bloom enclosing a copy of the provisional opinion regarding the legal case for compensation for people with haemophilia.

Published on:

Norma Guy suggested that the Haemophilia Society should be seen to be actively dealing with hepatitis, otherwise other groups would approach the press themselves.

Published on:

The Haemophilia Society planned the first Hepatitis Awareness Day for February 1994.

Published on:

The Independent ran a front-page article titled "Contaminated blood kills 12", in which Simon Taylor stated that the Haemophilia Society were considering seeking compensation.

Published on:

A review of the media campaign for people with haemophilia infected with Hepatitis C assessed that The Independent article brought down a media storm on the Society for which the Society was largely unprepared.

Published on:

Professor Bloom falsely reported that the Cardiff AIDS patient was back at work and in reasonably good health.

Published on:

The Haemophilia Society did not advise treatment policies which would have lessened the risks of infection whilst maintaining protection against the worst bleeds. It continued to adhere to its position that "factor VIII concentrates must continue to be imported from the USA".

Published on:

The Executive Committee of the Haemophilia Society had confirmed that the Cardiff case was indeed one of AIDS, but no questions were asked of Professor Bloom about this.

Published on:

The Haemophilia Society Executive Committee agreed unanimously in relation to AIDS that until the situation became clearer in relation to blood supplies, it would be wise for the Society to "wait and see".

Published on:

At a Haemophilia Society Executive Committee, Ken Milne (on behalf of the Blood Products Sub-Committee) introduced a "short and helpful discussion on attitudes to commercial factor VIII".

Published on:

The Haemophilia Society Executive Committee received a paper on commercial Factor 8 from Ken Milne and approved it after minor textual amendments

Published on:

The aims of the Haemophilia Society's HCV campaign were to press for the best treatment and care for people with haemophilia and related bleeding disorders infected with HCV.

Published on:

An agency was hired, at considerable cost, to steer the Haemophilia Society's HCV media campaign.

Published on:

When David Watters joined the Haemophilia Society in early 1981 there were two part-time secretaries working only in the mornings, who were the only other paid employees.

Published on:

In his oral evidence, David Watters described how at the outset his paid role was regarded with suspicion by a number of trustees.

Published on: